PI3K signalling in inflammation.

[1]  D. Calado,et al.  Germinal Centers , 2017, Methods in Molecular Biology.

[2]  Roberto Piñeiro,et al.  Inactivation of PI(3)K p110 delta breaks regulatory T-cell-mediated immune tolerance to cancer (vol 510, pg 407, 2014) , 2016 .

[3]  M. Huber,et al.  SHIP1 and the negative control of mast cell/basophil activation by supra-optimal antigen concentrations. , 2015, Molecular immunology.

[4]  Jean-Pierre Marquette,et al.  A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy. , 2014, Nature chemical biology.

[5]  E. Rosser,et al.  Cellular targets of regulatory B cell-mediated suppression. , 2014, Molecular immunology.

[6]  Koichi Araki,et al.  Autophagy is essential for effector CD8 T cell survival and memory formation , 2014, Nature Immunology.

[7]  H. Ueno,et al.  Phenotype and functions of memory Tfh cells in human blood. , 2014, Trends in immunology.

[8]  Michael J. Munson,et al.  Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase , 2014, The Biochemical journal.

[9]  Dalya R. Soond,et al.  Inactivation of the PI3K p110δ breaks regulatory T cell-mediated immune tolerance to cancer , 2014, Nature.

[10]  F. Jirik,et al.  NADPH Oxidase Modifies Patterns of MHC Class II–Restricted Epitopic Repertoires through Redox Control of Antigen Processing , 2014, The Journal of Immunology.

[11]  Lesley M. Chapman,et al.  Emerging roles for platelets as immune and inflammatory cells. , 2014, Blood.

[12]  G. Merlo,et al.  PI3K Class II α Controls Spatially Restricted Endosomal PtdIns3P and Rab11 Activation to Promote Primary Cilium Function , 2014, Developmental cell.

[13]  K. Okkenhaug,et al.  Haematological cancer: Idelalisib—targeting PI3Kδ in patients with B-cell malignancies , 2014, Nature Reviews Clinical Oncology.

[14]  Faith H. Brennan,et al.  PI3Kδ inhibition reduces TNF secretion and neuroinflammation in a mouse cerebral stroke model , 2014, Nature Communications.

[15]  L. Cantley,et al.  Idelalisib--a PI3Kδ inhibitor for B-cell cancers. , 2014, The New England journal of medicine.

[16]  P. Wei,et al.  Inhibition of PI3Kδ Improves Systemic Lupus in Mice , 2014, Inflammation.

[17]  T. Schumacher,et al.  TCR repertoires of intratumoral T‐cell subsets , 2014, Immunological reviews.

[18]  J. B. Oliveira,et al.  Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency , 2013, Nature Immunology.

[19]  A. Prescott,et al.  Characterization of VPS 34-IN 1 , a selective inhibitor of Vps 34 , reveals that the phosphatidylinositol 3-phosphate-binding SGK 3 protein kinase is a downstream target of class III phosphoinositide 3-kinase , 2014 .

[20]  Yasuyuki Fujii,et al.  Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase γ inhibitor for the treatment of inflammatory diseases. , 2013, Bioorganic & medicinal chemistry.

[21]  P. M. Abdul-Muneer,et al.  PI3Kγ inhibition alleviates symptoms and increases axon number in experimental autoimmune encephalomyelitis mice , 2013, Neuroscience.

[22]  H. Stenmark,et al.  Phosphoinositide 3‐kinases as accelerators and brakes of autophagy , 2013, The FEBS journal.

[23]  Bonnie Tillotson,et al.  PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models. , 2013, Chemistry & biology.

[24]  D. Fruman,et al.  Can Cancer Drugs Treat Immunodeficiency? , 2013, Science.

[25]  Nada Jabado,et al.  Phosphoinositide 3-Kinase δ Gene Mutation Predisposes to Respiratory Infection and Airway Damage , 2013, Science.

[26]  Roger L. Williams,et al.  Molecular determinants of PI3Kγ-mediated activation downstream of G-protein–coupled receptors (GPCRs) , 2013, Proceedings of the National Academy of Sciences.

[27]  S. Tauzin,et al.  Neutrophil migration: moving from zebrafish models to human autoimmunity , 2013, Immunological reviews.

[28]  T. Rao,et al.  PI3Kγ kinase activity is required for optimal T-cell activation and differentiation , 2013, European journal of immunology.

[29]  E. Hirsch,et al.  Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergy. , 2013, The Journal of allergy and clinical immunology.

[30]  H. Stenmark,et al.  Phosphatidylinositol 3‐phosphate, a lipid that regulates membrane dynamics, protein sorting and cell signalling , 2013, BioEssays : news and reviews in molecular, cellular and developmental biology.

[31]  N. Ktistakis,et al.  Omegasomes: PI3P platforms that manufacture autophagosomes. , 2013, Essays in biochemistry.

[32]  J. Downward,et al.  SnapShot: Class I PI3K Isoform Signaling , 2013, Cell.

[33]  R. Rickert.  New insights into pre-BCR and BCR signalling with relevance to B cell malignancies , 2013, Nature Reviews Immunology.

[34]  Je-in Youn,et al.  Reciprocal Relationship between Myeloid-Derived Suppressor Cells and T Cells , 2013, The Journal of Immunology.

[35]  Emilio Hirsch,et al.  PKCβ Phosphorylates PI3Kγ to Activate It and Release It from GPCR Control , 2013, PLoS biology.

[36]  F. Randow,et al.  The role of 'eat-me' signals and autophagy cargo receptors in innate immunity. , 2013, Current opinion in microbiology.

[37]  G. Stamp,et al.  RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms , 2013, Cell.

[38]  W. Zong,et al.  Class IA PI3K p110β subunit promotes autophagy through Rab5 small GTPase in response to growth factor limitation. , 2013, Molecular cell.

[39]  D. Finlay.  mTORC1 regulates CD8+ T-cell glucose metabolism and function independently of PI3K and PKB. , 2013, Biochemical Society transactions.

[40]  S. Matsuda,et al.  Class I PI3K-mediated Akt and ERK signals play a critical role in FcεRI-induced degranulation in mast cells. , 2013, International immunology.

[41]  Frank Noé,et al.  Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate , 2013, Nature.

[42]  K. Okkenhaug.  Signaling by the phosphoinositide 3-kinase family in immune cells. , 2013, Annual review of immunology.

[43]  P. Kubes,et al.  Neutrophil recruitment and function in health and inflammation , 2013, Nature Reviews Immunology.

[44]  E. Shevach,et al.  Absent C3a and C5a receptor signaling into CD4+ T cells enables auto-inductive TGF-β1 signaling and induction of Foxp3+ T regulatory cells , 2012, Nature Immunology.

[45]  Eric Vivier,et al.  Innate lymphoid cells — a proposal for uniform nomenclature , 2013, Nature Reviews Immunology.

[46]  K. Guan,et al.  Differential Regulation of Distinct Vps34 Complexes by AMPK in Nutrient Stress and Autophagy , 2013, Cell.

[47]  R. Sartor,et al.  Phosphatidylinositol 3-Kinase-γ Signaling Promotes Campylobacter jejuni–Induced Colitis through Neutrophil Recruitment in Mice , 2013, The Journal of Immunology.

[48]  S. Grinstein,et al.  Role of phospholipids in endocytosis, phagocytosis, and macropinocytosis. , 2013, Physiological reviews.

[49]  Mengrou Lu,et al.  Selective Inhibition of Phosphoinositide 3-Kinase p110α Preserves Lymphocyte Function* , 2012, The Journal of Biological Chemistry.

[50]  Roger L. Williams,et al.  G Protein–Coupled Receptor–Mediated Activation of p110β by Gβγ Is Required for Cellular Transformation and Invasiveness , 2012, Science Signaling.

[51]  K. Okkenhaug,et al.  Blockade of Phosphatidylinositol 3-Kinase (PI3K)δ or PI3Kγ Reduces IL-17 and Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis , 2012, The Journal of Immunology.

[52]  B. Vanhaesebroeck,et al.  The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock , 2012, Nature Immunology.

[53]  D. Whittington,et al.  Discovery and in Vivo Evaluation of Dual PI3K-beta/delta inhibitors , 2012 .

[54]  R. Schwartz,et al.  Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function , 2012, Nature Medicine.

[55]  S. Ward,et al.  Inhibition of PI3K Signaling Spurs New Therapeutic Opportunities in Inflammatory/Autoimmune Diseases and Hematological Malignancies , 2012, Pharmacological Reviews.

[56]  P. Hawkins,et al.  Functional Redundancy of Class I Phosphoinositide 3-Kinase (PI3K) Isoforms in Signaling Growth Factor-Mediated Human Neutrophil Survival , 2012, PloS one.

[57]  D. Whittington,et al.  PI3Kδ and PI3Kγ as targets for autoimmune and inflammatory diseases. , 2012, Journal of medicinal chemistry.

[58]  S. McColl,et al.  PI3Kγ Drives Priming and Survival of Autoreactive CD4+ T Cells during Experimental Autoimmune Encephalomyelitis , 2012, PloS one.

[59]  K. Okkenhaug,et al.  The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases , 2012, The open rheumatology journal.

[60]  A. Huttenlocher,et al.  Leukocyte migration from a fish eye's view , 2012, Journal of Cell Science.

[61]  D. Whittington,et al.  Discovery and in vivo evaluation of dual PI3Kβ/δ inhibitors. , 2012, Journal of medicinal chemistry.

[62]  M. Gold,et al.  Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies , 2012, Front. Immun..

[63]  J. Bazan,et al.  Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K , 2012, Cell cycle.

[64]  S. Ward,et al.  Targeting PI3K isoforms and SHIP in the immune system: new therapeutics for inflammation and leukemia. , 2012, Current opinion in pharmacology.

[65]  H. Stockinger,et al.  PI3Kδ Is Essential for Tumor Clearance Mediated by Cytotoxic T Lymphocytes , 2012, PloS one.

[66]  Y. Nishimura,et al.  GBF1 bears a novel phosphatidylinositol-phosphate binding module, BP3K, to link PI3Kγ activity with Arf1 activation involved in GPCR-mediated neutrophil chemotaxis and superoxide production , 2012, Molecular biology of the cell.

[67]  Dalya R. Soond,et al.  Does the PI3K pathway promote or antagonize regulatory T cell development and function? , 2012, Front. Immun..

[68]  R. Flavell,et al.  Canonical autophagy dependent on the class III phosphoinositide-3 kinase Vps34 is required for naive T-cell homeostasis , 2012, Proceedings of the National Academy of Sciences.

[69]  W. Elyaman,et al.  The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes , 2012, Diabetes.

[70]  P. Pandolfi,et al.  The functions and regulation of the PTEN tumour suppressor , 2012, Nature Reviews Molecular Cell Biology.

[71]  M. Falasca,et al.  Regulation and cellular functions of class II phosphoinositide 3-kinases. , 2012, The Biochemical journal.

[72]  A. Marshall,et al.  p110δ Phosphoinositide 3-Kinase Represses IgE Switch by Potentiating BCL6 Expression , 2012, The Journal of Immunology.

[73]  G. Krystal,et al.  The Role of SHIP in the Development and Activation of Mouse Mucosal and Connective Tissue Mast Cells , 2012, The Journal of Immunology.

[74]  D. Fruman,et al.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances. , 2012, The Biochemical journal.

[75]  E. Coustan-Smith,et al.  Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K , 2012, The Journal of experimental medicine.

[76]  V. Dixit,et al.  Signaling in innate immunity and inflammation. , 2012, Cold Spring Harbor perspectives in biology.

[77]  S. Weiss,et al.  MT1-MMP regulates the PI3Kδ·Mi-2/NuRD-dependent control of macrophage immune function. , 2012, Genes & development.

[78]  Markus Werner,et al.  FoxO1 induces Ikaros splicing to promote immunoglobulin gene recombination , 2012, The Journal of experimental medicine.

[79]  B. Stockinger,et al.  Regulation and function of innate and adaptive interleukin‐17‐producing cells , 2012, EMBO reports.

[80]  Janet L. Smith,et al.  Targeting phosphoinositide 3-kinase δ for allergic asthma. , 2012, Biochemical Society transactions.

[81]  C. Fedele,et al.  Phosphoinositide phosphatases: just as important as the kinases. , 2012, Sub-cellular biochemistry.

[82]  M. Janas,et al.  Interaction of Ras with P110γ is required for thymic beta- selection in the mouse , 2012 .

[83]  So Ri Kim,et al.  PI3K-γ Inhibition Ameliorates Acute Lung Injury Through Regulation of IκBα/NF-κB Pathway and Innate Immune Responses , 2011, Journal of Clinical Immunology.

[84]  J. Neefjes,et al.  Towards a systems understanding of MHC class I and MHC class II antigen presentation , 2011, Nature Reviews Immunology.

[85]  Ian Mcleod,et al.  The Class III Kinase Vps34 Promotes T Lymphocyte Survival through Regulating IL-7Rα Surface Expression , 2011, The Journal of Immunology.

[86]  M. Janas,et al.  Interaction of Ras with P110γ Is Required for Thymic β-Selection in the Mouse , 2011, The Journal of Immunology.

[87]  P. Kubes,et al.  The neutrophil in vascular inflammation , 2011, Nature Medicine.

[88]  John E. Burke,et al.  Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases , 2011, Science Signaling.

[89]  E. Hirsch,et al.  Phosphoinositide 3‐kinase p110γ in immunity , 2011, IUBMB life.

[90]  A. Iwasaki,et al.  Autophagy in the control and pathogenesis of viral infection. , 2011, Current opinion in virology.

[91]  Mark S. Sundrud,et al.  Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6+ human memory T cells , 2011, The Journal of experimental medicine.

[92]  L. Kane,et al.  Akt Fine-tunes NF-κB-dependent Gene Expression during T Cell Activation* , 2011, The Journal of Biological Chemistry.

[93]  S. Shears.  Faculty Opinions recommendation of Inositol hexakisphosphate kinase 1 regulates neutrophil function in innate immunity by inhibiting phosphatidylinositol-(3,4,5)-trisphosphate signaling. , 2011 .

[94]  P. Workman,et al.  Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors , 2011, Current medicinal chemistry.

[95]  S. Snyder,et al.  Inositol Hexakisphosphate Kinase 1 (insp6k1) Regulates Neutrophil Function in Innate Immunity by Inhibiting Ptdins(3,4,5)p3 Signaling Nih Public Access Author Manuscript Results Insp6k1 Disruption Augments Ptdins(3,4,5)p3 Signaling in Neutrophils Insp7 Inhibits Superoxide Production in a Cell Free S , 2022 .

[96]  S. McColl,et al.  PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. , 2011, Journal of autoimmunity.

[97]  R. Stockley,et al.  Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease. , 2011, American journal of respiratory and critical care medicine.

[98]  Yvonne Bordon.  Allergy: Shocking behaviour , 2011, Nature Reviews Immunology.

[99]  K. Okkenhaug,et al.  PI3Kβ Plays a Critical Role in Neutrophil Activation by Immune Complexes , 2011, Science Signaling.

[100]  E. Wakeland,et al.  Genetic predisposition to autoimmunity--what have we learned? , 2011, Seminars in immunology.

[101]  P. Worley,et al.  The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling , 2011, Nature Immunology.

[102]  S. Burridge.  Phosphatidylinositol 3-phosphate , 2011 .

[103]  W. Kerr,et al.  Inositol Phospholipid Signaling and the Biology of Natural Killer Cells , 2011, Journal of Innate Immunity.

[104]  P. Taylor,et al.  Class IA Phosphoinositide 3-Kinase β and δ Regulate Neutrophil Oxidase Activation in Response to Aspergillus fumigatus Hyphae , 2011, The Journal of Immunology.

[105]  C. Stadelmann,et al.  PI3Kγ deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcome , 2011, European journal of immunology.

[106]  David K. Finlay,et al.  Protein Kinase B Controls Transcriptional Programs that Direct Cytotoxic T Cell Fate but Is Dispensable for T Cell Metabolism , 2011, Immunity.

[107]  H. Virgin,et al.  Autophagy in immunity and inflammation , 2011, Nature.

[108]  Xiaoping Zhou,et al.  The Mammalian Class 3 PI3K (PIK3C3) Is Required for Early Embryogenesis and Cell Proliferation , 2011, PloS one.

[109]  G. Krystal,et al.  Role of SHIP in cancer. , 2011, Experimental hematology.

[110]  Daniel R. Beisner,et al.  Foxo transcription factors control regulatory T cell development and function. , 2010, Immunity.

[111]  K. Sauer,et al.  Lipid signaling in T-cell development and function. , 2010, Cold Spring Harbor perspectives in biology.

[112]  D. Powell,et al.  Requirement for Class II Phosphoinositide 3-Kinase C2α in Maintenance of Glomerular Structure and Function , 2010, Molecular and Cellular Biology.

[113]  Dalya R. Soond,et al.  Phosphoinositide 3-Kinase Activity in T Cells Regulates the Magnitude of the Germinal Center Reaction , 2010, The Journal of Immunology.

[114]  M. Boes,et al.  SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages , 2010, Nature Immunology.

[115]  Markus Werner,et al.  Role of PI3K in the generation and survival of B cells , 2010, Immunological reviews.

[116]  M. Hibbs,et al.  Plasma cell development and survival , 2010, Immunological reviews.

[117]  K. Okkenhaug,et al.  The PI3K Isoforms p110α and p110δ Are Essential for Pre–B Cell Receptor Signaling and B Cell Development , 2010, Science Signaling.

[118]  J. M. Bradshaw,et al.  The Src, Syk, and Tec family kinases: distinct types of molecular switches. , 2010, Cellular signalling.

[119]  Brigitta Stockinger,et al.  Effector T cell plasticity: flexibility in the face of changing circumstances , 2010, Nature Immunology.

[120]  R. DePinho,et al.  Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells , 2010, Nature Immunology.

[121]  Victor L. J. Tybulewicz,et al.  The SYK tyrosine kinase: a crucial player in diverse biological functions , 2010, Nature Reviews Immunology.

[122]  B. Vanhaesebroeck,et al.  The emerging mechanisms of isoform-specific PI3K signalling , 2010, Nature Reviews Molecular Cell Biology.

[123]  C. Chung,et al.  Phosphoinositide 3-kinase &dgr; inhibitor suppresses interleukin-17 expression in a murine asthma model , 2010, European Respiratory Journal.

[124]  Dalya R. Soond,et al.  PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans. , 2010, Blood.

[125]  E. Hirsch,et al.  PI3K inhibition in inflammation: Toward tailored therapies for specific diseases , 2010, BioEssays : news and reviews in molecular, cellular and developmental biology.

[126]  Adam D. Hoppe,et al.  A Cdc42 Activation Cycle Coordinated by PI 3-Kinase during Fc Receptor-mediated Phagocytosis , 2010, Molecular biology of the cell.

[127]  M. Turner,et al.  Thymic development beyond β-selection requires phosphatidylinositol 3-kinase activation by CXCR4 , 2010, The Journal of experimental medicine.

[128]  R. Gascoyne,et al.  Selective ablation of the YxxM motif of IL-7Rα suppresses lymphomagenesis but maintains lymphocyte development , 2009, Oncogene.

[129]  Fritz Melchers,et al.  Checkpoints in lymphocyte development and autoimmune disease , 2010, Nature Immunology.

[130]  P. Hawkins,et al.  PI3K signaling in neutrophils. , 2010, Current topics in microbiology and immunology.

[131]  J. Backer.  The regulation of class IA PI 3-kinases by inter-subunit interactions. , 2010, Current topics in microbiology and immunology.

[132]  Carl Nathan,et al.  Nonresolving Inflammation , 2010, Cell.

[133]  Prajwal,et al.  Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87/p110γ , 2009, Proceedings of the National Academy of Sciences.

[134]  L. Joosten,et al.  PI3Kγ regulates cartilage damage in chronic inflammatory arthritis , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[135]  T. Mak,et al.  Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase , 2009, Proceedings of the National Academy of Sciences.

[136]  R. Rickert,et al.  Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy. , 2009, Immunity.

[137]  Jimmy D Bell,et al.  Dominant Role of the p110β Isoform of PI3K over p110α in Energy Homeostasis Regulation by POMC and AgRP Neurons , 2009, Cell metabolism.

[138]  M. Gold,et al.  Phosphoinositide 3-Kinase p110δ Regulates Natural Antibody Production, Marginal Zone and B-1 B Cell Function, and Autoantibody Responses1 , 2009, The Journal of Immunology.

[139]  R. DePinho,et al.  PI3 Kinase Signals BCR-Dependent Mature B Cell Survival , 2009, Cell.

[140]  Xing Jun Li,et al.  A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. , 2009, Blood.

[141]  K. Okkenhaug,et al.  The p110δ Isoform of Phosphatidylinositol 3-Kinase Controls Susceptibility to Leishmania major by Regulating Expansion and Tissue Homing of Regulatory T Cells1 , 2009, The Journal of Immunology.

[142]  P. Worley,et al.  The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. , 2009, Immunity.

[143]  E. Hirsch,et al.  PI3Kγ Adaptor Subunits Define Coupling to Degranulation and Cell Motility by Distinct PtdIns(3,4,5)P3 Pools in Mast Cells , 2009, Science Signaling.

[144]  A. Rudensky,et al.  Control of regulatory T cell lineage commitment and maintenance. , 2009, Immunity.

[145]  Christopher S. Stevenson,et al.  Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice. , 2009, American journal of respiratory and critical care medicine.

[146]  C. Rommel,et al.  Leukocyte transmigration is modulated by chemokine‐mediated PI3Kγ‐dependent phosphorylation of vimentin , 2009, European journal of immunology.

[147]  Takehiko Sasaki,et al.  Allergic airway hyperresponsiveness, inflammation, and remodeling do not develop in phosphoinositide 3-kinase gamma-deficient mice. , 2009, The Journal of allergy and clinical immunology.

[148]  C. Münz.  Enhancing immunity through autophagy. , 2009, Annual review of immunology.

[149]  G. Noronha,et al.  Aerosolized Phosphoinositide 3-Kinase γ/δ Inhibitor TG100-115 [3-[2,4-Diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a Therapeutic Candidate for Asthma and Chronic Obstructive Pulmonary Disease , 2009, Journal of Pharmacology and Experimental Therapeutics.

[150]  D. Fruman,et al.  Fine tuning the immune response with PI3K , 2009, Immunological reviews.

[151]  D. Broide,et al.  PI3K gamma-deficient mice have reduced levels of allergen-induced eosinophilic inflammation and airway remodeling. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[152]  M. Gold,et al.  Phosphoinositide 3-Kinase p110 Regulates Natural Antibody Production, Marginal Zone and B-1 B Cell Function, and Autoantibody Responses , 2009 .

[153]  Steven J. Lingard,et al.  Dominant Role of the p 110 beta Isoform of PI 3 K over p 110 alpha in Energy Homeostasis Regulation by POMC and AgRP Neurons , 2009 .

[154]  H. Karasuyama,et al.  Newly discovered roles for basophils: a neglected minority gains new respect , 2009, Nature Reviews Immunology.

[155]  P. Hawkins,et al.  CD18-dependent activation of the neutrophil NADPH oxidase during phagocytosis of Escherichia coli or Staphylococcus aureus is regulated by class III but not class I or II PI3Ks. , 2008, Blood.

[156]  D. Farber,et al.  Recalling the Year in Memory T Cells , 2008, Annals of the New York Academy of Sciences.

[157]  A. Singer,et al.  Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice , 2008, Nature Reviews Immunology.

[158]  K. Shokat,et al.  Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production. , 2008, The Journal of allergy and clinical immunology.

[159]  Jason S. Mitchell,et al.  The p110γ isoform of phosphatidylinositol 3‐kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites , 2008, Journal of leukocyte biology.

[160]  Joel A. Swanson,et al.  Shaping cups into phagosomes and macropinosomes , 2008, Nature Reviews Molecular Cell Biology.

[161]  Hidde L. Ploegh,et al.  The known unknowns of antigen processing and presentation , 2008, Nature Reviews Immunology.

[162]  R. Medzhitov.  Origin and physiological roles of inflammation , 2008, Nature.

[163]  K. Okkenhaug,et al.  The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ , 2008, Proceedings of the National Academy of Sciences.

[164]  P. Hawkins,et al.  Moving towards a Better Understanding of Chemotaxis , 2008, Current Biology.

[165]  M. Schlissel,et al.  Foxo1 directly regulates the transcription of recombination-activating genes during B cell development , 2008, Nature Immunology.

[166]  Holger Gerhardt,et al.  Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration , 2008, Nature.

[167]  T. Diacovo,et al.  Role of PI3Kδ and PI3Kγ in inflammatory arthritis and tissue localization of neutrophils , 2008, European journal of immunology.

[168]  C. Rommel,et al.  Genetic and Pharmacological Targeting of Phosphoinositide 3-Kinase-&ggr; Reduces Atherosclerosis and Favors Plaque Stability by Modulating Inflammatory Processes , 2008, Circulation.

[169]  C. Rommel,et al.  Isoform-Specific Functions of Phosphoinositide 3-Kinases: p110δ but Not p110γ Promotes Optimal Allergic Responses In Vivo1 , 2008, The Journal of Immunology.

[170]  S. Jameson,et al.  Selective Regulation of CD8 Effector T Cell Migration by the p110γ Isoform of Phosphatidylinositol 3-Kinase1 , 2008, The Journal of Immunology.

[171]  J. Backer.  The regulation and function of Class III PI3Ks: novel roles for Vps34. , 2008, The Biochemical journal.

[172]  K. Okkenhaug,et al.  CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. , 2008, Blood.

[173]  M. Lemmon,et al.  Membrane recognition by phospholipid-binding domains , 2008, Nature Reviews Molecular Cell Biology.

[174]  T. Yamazaki,et al.  Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase. , 2008, Blood.

[175]  C. Rommel,et al.  Isoform-specific functions of phosphoinositide 3-kinases: p110 delta but not p110 gamma promotes optimal allergic responses in vivo. , 2008, Journal of immunology.

[176]  R. DePinho,et al.  Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation , 2008, Nature Immunology.

[177]  P. Hawkins,et al.  CD 18-dependent activation of the neutrophil NADPH oxidase during phagocytosis of Escherichia coli or Staphylococcus aureus is regulated by class III but not class I or II PI 3 Ks , 2008 .

[178]  M. Camps,et al.  The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion. , 2007, Blood.

[179]  K. Okkenhaug,et al.  Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation. , 2007, Blood.

[180]  M. Cybulsky,et al.  Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.

[181]  S. Schurmans,et al.  Phosphoinositide phosphatases in a network of signalling reactions , 2007, Pflügers Archiv - European Journal of Physiology.

[182]  Lewis C. Cantley,et al.  AKT/PKB Signaling: Navigating Downstream , 2007, Cell.

[183]  David K. Finlay,et al.  Notch-induced T cell development requires phosphoinositide-dependent kinase 1 , 2007, The EMBO journal.

[184]  R. Hardy,et al.  The protean nature of cells in the B lymphocyte lineage. , 2007, Immunity.

[185]  P. Libby,et al.  Deletion of the phosphoinositide 3-kinase p110γ gene attenuates murine atherosclerosis , 2007, Proceedings of the National Academy of Sciences.

[186]  K. Preissner,et al.  Importance of Phosphoinositide 3-Kinase γ in the Host Defense against Pneumococcal Infection , 2007 .

[187]  C. Rommel,et al.  PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond? , 2007, Nature Reviews Immunology.

[188]  K. Okkenhaug,et al.  Role of the phosphoinositide 3‐kinase p110δ in generation of type 2 cytokine responses and allergic airway inflammation , 2007, European journal of immunology.

[189]  S. Bischoff.  Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data , 2007, Nature Reviews Immunology.

[190]  K. Preissner,et al.  Importance of phosphoinositide 3-kinase gamma in the host defense against pneumococcal infection. , 2007, American journal of respiratory and critical care medicine.

[191]  C. Rommel,et al.  PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? , 2007, Nature reviews. Immunology.

[192]  P. Finan,et al.  PI(3)Kgamma has an important context-dependent role in neutrophil chemokinesis. , 2007, Nature cell biology.

[193]  P. Finan,et al.  PI(3)Kγ has an important context-dependent role in neutrophil chemokinesis , 2007, Nature Cell Biology.

[194]  T. Mak,et al.  Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1 , 2007, Nature Cell Biology.

[195]  K. Ley,et al.  Leukocyte phosphoinositide‐3 kinase γ is required for chemokine‐induced, sustained adhesion under flow in vivo , 2006, Journal of leukocyte biology.

[196]  K. Okkenhaug,et al.  Cutting Edge: The Phosphoinositide 3-Kinase p110δ Is Critical for the Function of CD4+CD25+Foxp3+ Regulatory T Cells1 , 2006, The Journal of Immunology.

[197]  Phillip T. Hawkins,et al.  Gβγs and the Ras binding domain of p110γ are both important regulators of PI3Kγ signalling in neutrophils , 2006, Nature Cell Biology.

[198]  K. Okkenhaug,et al.  The p110δ Isoform of Phosphoinositide 3-Kinase Controls Clonal Expansion and Differentiation of Th Cells1 , 2006, The Journal of Immunology.

[199]  P. Hawkins,et al.  PtdIns3P binding to the PX domain of p40phox is a physiological signal in NADPH oxidase activation , 2006, The EMBO journal.

[200]  K. Calame,et al.  Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling. , 2006, Immunity.

[201]  P. Hawkins,et al.  Signalling through Class I PI3Ks in mammalian cells. , 2006, Biochemical Society transactions.

[202]  P. Hawkins,et al.  Neutrophils from p40phox−/− mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing , 2006, The Journal of experimental medicine.

[203]  M. Yaffe,et al.  The phosphoinositide-binding protein p40phox activates the NADPH oxidase during FcγIIA receptor–induced phagocytosis , 2006, The Journal of experimental medicine.

[204]  Ji Luo,et al.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism , 2006, Nature Reviews Genetics.

[205]  G. Raposo,et al.  NOX2 Controls Phagosomal pH to Regulate Antigen Processing during Crosspresentation by Dendritic Cells , 2006, Cell.

[206]  K. Okkenhaug,et al.  Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation , 2006, Nature.

[207]  W. Fridman,et al.  The SH2 domain-containing inositol 5-phosphatase SHIP1 is recruited to the intracytoplasmic domain of human FcgammaRIIB and is mandatory for negative regulation of B cell activation. , 2006, Immunology letters.

[208]  W. Swat,et al.  Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival. , 2006, Blood.

[209]  V. Nizet,et al.  Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer , 2006, Cell.

[210]  Hervé Guillou,et al.  Gbetagammas and the Ras binding domain of p110gamma are both important regulators of PI(3)Kgamma signalling in neutrophils. , 2006, Nature cell biology.

[211]  P. Khavari,et al.  The Class II Phosphoinositide 3-Kinase C2β Is Not Essential for Epidermal Differentiation , 2005, Molecular and Cellular Biology.

[212]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[213]  E. Vigorito,et al.  Cutting Edge: T Cell Development Requires the Combined Activities of the p110γ and p110δ Catalytic Isoforms of Phosphatidylinositol 3-Kinase1 , 2005, The Journal of Immunology.

[214]  Emilio Hirsch,et al.  Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis , 2005, Nature Medicine.

[215]  D. F. Barber,et al.  PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus , 2005, Nature Medicine.

[216]  K. Okkenhaug,et al.  Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. , 2005, Blood.

[217]  J. Penninger,et al.  The role of endothelial PI3Kgamma activity in neutrophil trafficking. , 2005, Blood.

[218]  P. Hawkins,et al.  p84, a New Gβγ-Activated Regulatory Subunit of the Type IB Phosphoinositide 3-Kinase p110γ , 2005, Current Biology.

[219]  A. Marshall,et al.  Role of the adaptor proteins Bam32, TAPP1 and TAPP2 in lymphocyte activation. , 2005, Immunology letters.

[220]  M. Dinauer.  Chronic granulomatous disease and other disorders of phagocyte function. , 2005, Hematology. American Society of Hematology. Education Program.

[221]  C. Garlanda,et al.  Defective dendritic cell migration and activation of adaptive immunity in PI3Kγ‐deficient mice , 2004 .

[222]  L. Silengo,et al.  PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects , 2004, Cell.

[223]  M. Murakami,et al.  mTOR Is Essential for Growth and Proliferation in Early Mouse Embryos and Embryonic Stem Cells , 2004, Molecular and Cellular Biology.

[224]  T. Graf,et al.  Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue. , 2004, Blood.

[225]  M. Czech,et al.  Phosphatidylinositol-3-Phosphate , 2004 .

[226]  E. Prigmore,et al.  Requirement for PI 3-kinase γ in macrophage migration to MCP-1 and CSF-1 , 2003 .

[227]  K. Okkenhaug,et al.  Class I Phosphoinositide 3-Kinase p110β Is Required for Apoptotic Cell and Fcγ Receptor-mediated Phagocytosis by Macrophages* , 2003, Journal of Biological Chemistry.

[228]  P. Coffer,et al.  FOXO Transcription Factors as Regulators of Immune Homeostasis: Molecules to Die for? , 2003, The Journal of Immunology.

[229]  P. Kidd.  Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. , 2003, Alternative medicine review : a journal of clinical therapeutic.

[230]  Marketa Zvelebil,et al.  Phosphoinositide 3-kinase signalling--which way to target? , 2003, Trends in pharmacological sciences.

[231]  Amber C. Donahue,et al.  Proliferation and Survival of Activated B Cells Requires Sustained Antigen Receptor Engagement and Phosphoinositide 3-Kinase Activation1 , 2003, The Journal of Immunology.

[232]  D. Staunton,et al.  Essential Role of Phosphoinositide 3-Kinase δ in Neutrophil Directional Movement , 2003, The Journal of Immunology.

[233]  M. Hughes,et al.  Role of Src homology 2-containing-inositol 5'-phosphatase (SHIP) in mast cells and macrophages. , 2001, Biochemical Society transactions.

[234]  S. Akira,et al.  Toll-like receptors. , 2003, Annual review of immunology.

[235]  D. Staunton,et al.  Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement. , 2003, Journal of immunology.

[236]  K. Okkenhaug,et al.  Class I phosphoinositide 3-kinase p110beta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages. , 2003, The Journal of biological chemistry.

[237]  E. Prigmore,et al.  Requirement for PI 3-kinase gamma in macrophage migration to MCP-1 and CSF-1. , 2003, Experimental cell research.

[238]  P. Kidd.  Th 1 / Th 2 Balance : The Hypothesis , its Limitations , and Implications for Health and Disease , 2003 .

[239]  Carl Nathan,et al.  Points of control in inflammation , 2002, Nature.

[240]  J. Ihle,et al.  Essential, Nonredundant Role for the Phosphoinositide 3-Kinase p110δ in Signaling by the B-Cell Receptor Complex , 2002, Molecular and Cellular Biology.

[241]  E. Vigorito,et al.  A Crucial Role for the p110δ Subunit of Phosphatidylinositol 3-Kinase in B Cell Development and Activation , 2002, The Journal of experimental medicine.

[242]  Sergio Grinstein,et al.  Phagosome maturation: aging gracefully. , 2002, The Biochemical journal.

[243]  K. Okkenhaug,et al.  Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice , 2002, Science.

[244]  R. Bleackley,et al.  Cytotoxic T lymphocytes: all roads lead to death , 2002, Nature Reviews Immunology.

[245]  P. Finan,et al.  Phosphoinositide 3-Kinase γ Is an Essential Amplifier of Mast Cell Function , 2002 .

[246]  P. Finan,et al.  Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function. , 2002, Immunity.

[247]  P. Lipp,et al.  Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. , 2002, Molecular cell.

[248]  P. Lipp,et al.  Phosphatidylinositol 3-phosphate is generated in phagosomal membranes , 2001, Current Biology.

[249]  S. Grinstein,et al.  Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation , 2001, The Journal of cell biology.

[250]  C. Fathman,et al.  Autoimmune diseases: genes, bugs and failed regulation , 2001, Nature Immunology.

[251]  J. C. Pratt,et al.  Essential role for Gab2 in the allergic response , 2001, Nature.

[252]  J. C. Pratt,et al.  Gu, H. et al. Essential role for Gab2 in the allergic response. Nature 412, 186-190 , 2001 .

[253]  G. Krystal,et al.  Lipid phosphatases in the immune system. , 2000, Seminars in immunology.

[254]  Silvano Sozzani,et al.  Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation , 2000 .

[255]  Dianqing Wu,et al.  Roles of PLC-β2 and -β3 and PI3Kγ in Chemoattractant-Mediated Signal Transduction , 2000 .

[256]  W L Stanford,et al.  Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. , 2000, Science.

[257]  C. Garlanda,et al.  Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. , 2000, Science.

[258]  Z. Li,et al.  Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. , 2000, Science.

[259]  R. Nussbaum,et al.  Proliferative Defect and Embryonic Lethality in Mice Homozygous for a Deletion in the p110α Subunit of Phosphoinositide 3-Kinase* , 1999, The Journal of Biological Chemistry.

[260]  C. Tseng,et al.  A Requirement for Phosphatidylinositol 3-Kinase in Pseudopod Extension* , 1999, The Journal of Biological Chemistry.

[261]  P. Hawkins,et al.  Priming of human neutrophil superoxide generation by tumour necrosis factor‐α is signalled by enhanced phosphatidylinositol 3,4,5‐trisphosphate but not inositol 1,4,5‐trisphosphate accumulation , 1998, FEBS letters.

[262]  L. Stephens,et al.  Pathway of phosphatidylinositol(3,4,5)-trisphosphate synthesis in activated neutrophils , 1991, Nature.

[263]  B. Bainbridge,et al.  Genetics , 1981, Experientia.